Our stories

Though they come from different backgrounds, our scientists share a passion and dedication to pushing our science forward. Meet the people driving innovation at Vertex.

Understanding the real-life impacts of managing SCD and TDT.

Chief Human Resources Officer Stephanie Franklin discusses our unique culture at Vertex and how we bring our culture to life.

Learn how we explore the daily lives of those living with debilitating disease to help inform our mission.

Learn how our teams utilize real-world research to understand the lived impacts of sickle cell disease and beta thalassemia.

Vertex is committed to the sickle cell disease community. Beyond our science, it’s about showing up and locking arms with the community to work together toward meaningful change.

Vice President of Clinical Development Dr. Ogo Egbuna shares why it’s important to raise awareness about APOL1-mediated kidney disease (AMKD). 

We are relentless in our quest to improve the lives of people living with serious diseases. Thanks to the dedication of teams led by Paul Negulescu, Fred Van Goor and Sabine Hadida, our medicines have profoundly impacted the cystic fibrosis community.

Learn more about cystic fibrosis and how we are committed now more than ever to discovering new therapeutic advances for all people living with the disease.

Learn why the Vertex Pharmaceuticals approach to career growth is unique from Chief Human Resources Officer Stephanie Franklin.

The Vertex Foundation Scholarship helps eligible people with cystic fibrosis and their families in the U.S. and Canada pursue higher education degrees. Recipients will be awarded $5,000 USD/CAD toward the 2023-2024 academic year. 

Unique summer camp experiences dedicated to the siblings of children with a serious illness? Sign us up! Having a child with a serious illness impacts the whole family, and sibling camp is just one way the Vertex Foundation supports healthy families across the globe. 

Listen to our new podcast, Targeting the Toughest Diseases, created in partnership with Bloomberg Media Studios, to learn about the innovative tools, methods and unique philosophy we use in our search for treatments and cures.

ID&E Week is our annual opportunity to press pause and listen, learn and reflect. This year’s theme, “Catalysts for Change,” was also a call to action for Vertexians to ignite actionable change. Hear from Vice President Diana Cruz Solash on key takeaways from our sixth annual ID&E Week. 

Giving back is part of our culture, so much so that we say it’s in our DNA. Vertex’s 14th annual Global Day of Service was our most impactful to date, with 57% employee participation across 20 countries and more than 6,000 hours of service contributed to our communities. 

September is Pain Awareness Month in the U.S., dedicated to raising public awareness around pain, pain management and the work that pain professionals do every day. Hear from Vice President Jim Jones on why his career led him to clinical development for our pain program. 

The Sickle Cell Disease Partnership is a multistakeholder coalition, launched in June, which works to improve care and access for people living with sickle cell disease. Here, Chief Patient Officer Amit Sachdev discusses the partnership, its goals and the reasons it was founded.

Supporting healthy families is one focus of the Vertex Foundation. Executive Director Katharine Jensen shares how the Foundation is expanding its partnership with Ronald McDonald House Charities in new and innovative ways.

Our commitment to inclusion, diversity and equity (ID&E) is longstanding and achieving our ambition takes collective action and shared ownership. Learn more about our approach from Vice President of Talent and ID&E Diana Cruz Solash.